Found: 13
Select item for more details and to access through your institution.
Huntington's disease: from experimental results to interaction networks, patho-pathway construction and disease hypothesis.
- Published in:
- 2007
- By:
- Publication type:
- Abstract
Microhabitats, macro-differences: a survey of temperature records in Victoria Land terrestrial and freshwater environments.
- Published in:
- Antarctic Science, 2022, v. 34, n. 3, p. 256, doi. 10.1017/S0954102022000050
- By:
- Publication type:
- Article
Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.
- Published in:
- BMC Biochemistry, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2091-14-34
- By:
- Publication type:
- Article
A Radial Glia Gene Marker, Fatty Acid Binding Protein 7 (FABP7), Is Involved in Proliferation and Invasion of Glioblastoma Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052113
- By:
- Publication type:
- Article
A Continuous Time-Resolved Fluorescence Assay for Identification of BACE1 Inhibitors.
- Published in:
- Assay & Drug Development Technologies, 2005, v. 3, n. 3, p. 287
- By:
- Publication type:
- Article
Sequential detergent fractionation of primary neurons for proteomics studies.
- Published in:
- Proteomics, 2008, v. 8, n. 5, p. 930, doi. 10.1002/pmic.200700738
- By:
- Publication type:
- Article
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 3, p. 465, doi. 10.1111/bcp.12512
- By:
- Publication type:
- Article
Safety, pharmacokinetics, pharmacogenomics and QT concentration−effect modelling of the SirT1 inhibitor selisistat in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 3, p. 477, doi. 10.1111/bcp.12513
- By:
- Publication type:
- Article
Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells.
- Published in:
- Bioscience Reports, 2011, v. 31, n. 1, p. 45, doi. 10.1042/BSR20100018
- By:
- Publication type:
- Article
Robust MS quantification method for phospho-peptides using <sup>18</sup>O/<sup>16</sup>O labeling.
- Published in:
- BMC Bioinformatics, 2009, v. 10, p. 1, doi. 10.1186/1471-2105-10-141
- By:
- Publication type:
- Article
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.
- Published in:
- Nature Communications, 2015, v. 6, n. 6, p. 7227, doi. 10.1038/ncomms8227
- By:
- Publication type:
- Article
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 11, p. 2995, doi. 10.1093/hmg/ddu010
- By:
- Publication type:
- Article
In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 2, p. E33, doi. 10.1002/ijc.27349
- By:
- Publication type:
- Article